SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Fifth Street Finance Corp., Fifth Street Asset Management, Inc. and Certain Officers – FSC - FSAM

NEW YORK, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fifth Street Finance Corp., Fifth Street Asset Management, Inc. (“FSC” or the “Company”) (NASDAQ: FSC ), (“FSAM” or the “Company”) (NASDAQ: FSAM ) and certain of its officers.   The class action, filed in United States District Court, Southern District of New York, and docketed under 15-cv-08908, is on behalf of a class consisting of all persons or entities who purchased FSC and FSAM securities between July 7, 2014 and February 6, 2015 inclusive (the “Class Period”).  This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).  

If you are a shareholder who purchased FSC and FSAM securities during the Class Period, you have until November 30, 2015 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Fifth Street is a credit-focused asset management enterprise founded by defendant Leonard M. Tannenbaum ("Tannenbaum"). FSC is a publicly traded asset portfolio company within the Fifth Street family of companies. FSC lends to and invests in small and mid­sized companies in connection with investments by private equity sponsors with the stated goal of generating investment income, which are then paid out as dividends to FSC shareholders.

FSAM is the asset manager and investment advisor for FSC, from which it receives tens of millions of dollars annually for the provision of investment advisory services. As of June 30, 2014, FSC provided about 90% of FSAM's assets under management, and thus the asset manager's primary revenue source. The amount of fees paid by FSC to FSAM is largely determined by FSC's gross portfolio assets. Thus, FSAM may increase the amount of fees it receives from FSC by borrowing money to make additional investments that increase the size of FSC's asset portfolio. FSC primarily invests in illiquid assets and uses a form of fair value accounting that prevents investors and the market from being able to independently ascertain the credit quality and actual performance of the Company's investments, while allowing the Company to record investment income (thereby increasing fees paid to FSAM) even if that income is never collected.

The Complaint alleges that throughout the Class Period, defendants engaged in a fraudulent scheme and course of business designed to artificially inflate FSC's assets and investment income in order to increase FSAM's revenue. Specifically, defendants pushed FSC into increasingly risky, speculative investments at unsustainable leverage levels, delayed writing down impaired investments in order to create the appearance of increasing revenues for FSAM, and systematically overstated the income generated by FSC's investments and the fair value of its portfolio, while simultaneously providing investors and the market with false and misleading portrayals of FSC's business trends and expected performance.

On February 9, 2015, FSC reported its fiscal results for the quarter ended December 31, 2014 the same quarter in which defendants conducted the FSAM IPO. FSC revealed that, around the time its executives were taking FSAM public, it had moved $106 million worth of investments to non-accrual status with an additional $17 million likely to be designated non-accrual in the subsequent quarter, which together constituted about 5% of the Company's entire debt investment portfolio on a cost basis. The Company also revealed that, even though the total assets of FSC's investment portfolio had continued to increase to nearly $3 billion by quarter end, the net investment income received by the Company had actually decreased by 6% compared to the prior quarter. And, despite having announced a 10% dividend increase only four months before taking FSAM public, FSC declared that it would issue zero dividends for February 2015, while decreasing future dividend payments by more than 30% as part of a more "conservative" dividend policy.

On this news, the price of FSC common stock plummeted $1.27 per share on February 9, 2015 to close at $7.22 per share, a decline of nearly 15% on volume of 10.9 million shares.

On February 23, 2015, Fitch Ratings Inc. downgraded FSC to BB+ from BBB- on a negative outlook, citing "FSC's higher leverage levels, combined with increased portfolio risk, an inconsistent dividend policy, material portfolio growth in a very competitive underwriting environment, asset quality deterioration, and weaker operating performance." By August 7, 2015, the price of FSC common stock had fallen to $6.11 per share at closing, 40% below the Class Period high of $10.10 per share.

On October 29, 2014, defendants sold 6 million FSAM shares for $17 per share, with Leonard M. Tannenbaum and his associates receiving tens of millions of dollars from the sale of their shares in the Initial Public Offering ("IPO").

The Pomerantz Firm, ith offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rising Medical Lands Ninth Spot on Inc. 5000

Updated Category News Views 105

Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 101

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
GreenCore's Agentic Shopping Hub: Disrupting FMCG Market

Updated Category News Views 34

GreenCore's Bold Move in FMCG Retail Just when you thought retail couldn't get any more futuristic, here comes GreenCore Solutions Corp. (GSC) shaking up the game with their Agentic Shopping Hub. For the uninitiated, we're not just talking about another e-commerce gimmick—this is a cultural shift. FMCG brands are being told to 'bring their agent' into a realm where AI...

Continue Reading
JELD-WEN Q3 2026: Fighting Headwinds, Shows Progress

Updated Category News Views 24

Challenging Market Yet Strategic Steps Talk about a seesaw of a quarter for JELD-WEN, folks. On the one hand, their net revenues took a dip to $798.5 million, shaving off 1.4% from last year. If you ask why, blame it on a 2% slide in volume/mix. That uptick in price? Well, 1% wasn't enough to save the day. "Our third-quarter results reflect the continued progress we are...

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 215

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 54

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
Metals Producers Rise Despite Futures Dip: Election Day Buzz

Updated Category News Views 40

Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 34

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Qfin Holdings Faces Securities Fraud Class Action Challenges

Updated Category News Views 73

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 53

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading

Top 5 Most Recently Viewed Articles

Swisslog and Medline Enhance Supply Chain with Automation Solution

Updated Category News Views 181

Swisslog and Medline Enhance Supply Chain with Automation Solution Swisslog, a recognized leader in logistics automation, has embarked on an exciting new project with Medline, a long-standing partner. This collaboration focuses on the implementation of an advanced AutoStore system designed to significantly enhance Medline's order fulfillment capabilities. The New...

Continue Reading
Revolutionizing Healthcare with Wearable Electronic Records

Updated Category News Views 149

Revolutionizing Healthcare with Wearable Electronic Records In an exciting advancement for digital health, Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) has announced a groundbreaking partnership with MyID, a leader in wearable medical identification technology. This joint venture aims to introduce the first-ever device that integrates a user’s complete, verified...

Continue Reading
Innovative EVV Solutions Introduced for Care Providers in Michigan

Updated Category News Views 112

Therap Integrates with EVV Aggregator for Enhanced Care Therap Services, a leader in HIPAA-compliant electronic documentation solutions, is taking significant strides forward in support of care providers. By integrating with a new Electronic Visit Verification (EVV) aggregator, Therap aims to enhance the services provided to patients receiving Medicaid personal care and...

Continue Reading
Jabil's Bright Future: Earnings Surge and Strategic Growth Ahead

Updated Category News Views 223

Jabil's stock saw some serious action back in 2024 when BofA Securities hiked its price target from $135 to $150 after a strong Q4 earnings report. They slapped a Buy rating on it, and you know how that goes—traders perk up when the analysts start buzzing about positive outlooks. For fiscal year 2025, Jabil was predicting revenues of around $27 billion and an EPS of...

Continue Reading
AdTech Holding Celebrates Prestigious Workplace Certification

Updated Category News Views 110

AdTech Holding Achieves Recognition for Workplace Excellence AdTech Holding has recently earned the esteemed Great Place To Work® Certification™ for the third consecutive year. This notable achievement reflects the genuine feedback from employees concerning the workplace culture, trust, and the opportunities for professional growth that the company fosters. A...

Continue Reading